- US-listed companies
- CollPlant Biotechnologies Ltd
CollPlant Biotechnologies LtdCLGN
Market cap
P/E ratio
Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | |
Total revenues | 2 | 6 | 16 | 0 |
Cost of revenues | 2 | 3 | 2 | 0 |
Gross Profit (loss) | 0 | 3 | 14 | -0 |
Research and development | 0 | 4 | 8 | 10 |
General, administrative and marketing | - | 5 | 6 | 7 |
Total operating income (loss) | -8 | -6 | 0 | -17 |
Financial income (expenses), net | - | - | 0 | 0 |
Net income (loss) | -11 | -6 | 0 | -17 |
Basic net income (loss) per ordinary share (in Dollars per share) | - | - | 0.02 | -1.53 |
Diluted net income (loss) per ordinary share (in Dollars per share) | - | - | 0.02 | -1.53 |